Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > GKOS Glaukos > Main Composition
GKOS Glaukos
47.820
-0.840-1.73%
Post Mkt Price
47.8200.0000.00%
All
YOY
Do not show
Business Unit:USD
nameYOYOperating income%
Glaucoma--231.98M78.90%
Corneal Health--62.03M21.10%
Region Unit:USD
nameYOYOperating income%
United States--223.79M76.12%
International--70.22M23.88%
Company Overview More
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in San Clemente, CA.
CEO: Mr. Thomas W. Burns
Market: NYSE
Listing Date: 06/25/2015
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist